ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychologist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,644Medicare Part D Prescriptions Filled, Including Refills
$1.48M Total Retail Price of All Prescriptions
577 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
NAMENDA 1,363 1,330
ESCITALOPRAM OXALATE 994 883
ZOLPIDEM TARTRATE 647 485
EXELON 526 518
LEXAPRO 442 388
SERTRALINE HCL 403 262
ABILIFY 328 114
CYMBALTA 292 163
DONEPEZIL HCL 254 244
BUPROPION XL 244 99
TRAZODONE HCL 243 107
RISPERIDONE 219 98
CITALOPRAM HBR 209 135
VENLAFAXINE HCL ER 177 102
OLANZAPINE 176 67
QUETIAPINE FUMARATE 168 86
FLUOXETINE HCL 146 43
VIIBRYD 119 67
DIVALPROEX SODIUM ER 113 34
MIRTAZAPINE 109 76
PRISTIQ ER 105 11
LAMOTRIGINE 105 22
PAROXETINE HCL 104 77
LITHIUM CARBONATE 92 21
SEROQUEL XR 80 11
SEROQUEL 75 37
BUSPIRONE HCL 74 48
PERPHENAZINE 71 0
TOPIRAMATE 67 0
BENZTROPINE MESYLATE 65 0 R
ZALEPLON 65 53
ZIPRASIDONE HCL 60 0
LUNESTA 59 26
DOXEPIN HCL 59 38
GABAPENTIN 58 16
METHYLPHENIDATE HCL 57 0
FANAPT 55 14
CLONAZEPAM 53 33
BUPROPION HCL SR 52 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.